Font Size: a A A
Keyword [Chronic Myelogenous Leukemia]
Result: 141 - 160 | Page: 8 of 10
141. Analysis Of The Efficacy After Discontinuation Of Tyrosine Kinase Inhibitors Treatment In Patients With Chronic Myelogenous Leukemia
142. Study On Icaritin Suppress Hematological Malignancies Through Inducing Production Of Reactive Oxygen Species
143. Analysis The Treatment Of Imatinib In Chronic Myeloid Leukemia Of Chronic Phase About The Different Ethnic Group
144. Targeting Histone Lysine Methyltransferase EZH2 Eliminates Leukemia Stem Cells And Its Underlying Mechanism In Chronic Myelogenous Leukemia
145. The Role Of HOTAIR In The Imatinib Resistance In Chronic Myeloid Leukemia Cells
146. The Mechanism Of EphB4/ephrinB2 Mediated IM Resistance In Chronic Myelogenous Leukemia Through Microenvironment In Bone Marrow
147. Retrospective Clinical Study Of Nilotinib As A Second-line Therapy In Imatinib Treatment-failure Patients With Chronic Myeloid Leukemia In Chronic Phase
148. LncRNA119766-miR-124-3p-CRKL Axis Mediating The Malignant Behaviors Of K562 Cell Via PI3K/AKT Pathway
149. The Roles Of Abnormal Epigenetic Of P53 And Oxidative Damage In The Resistance Of Chronic Myeloid Leukemia To Imatinib
150. The Role Of Long Non-coding RNA H19 And Their Identification Of Targets In Chronic Myelogenous Leukemia(CML) Cells
151. The Role Of HNRPDL In Chronic Myelogenous Leukemia Cells
152. Antitumor Activity Of Trifluoromethyl Benzamides XX03529 In Human Chronic Myelogenous Leukemia Cell Line K562 And Its Mechanism Of Action
153. Basic Study On The Effects Of Arsenic Trioxide On Molecular Of Hedgehog Signaling Pathway In Chronic Myelogenous Leukemia
154. Mechanism Of Lycosin-I Selectively Inhibiting The Chronic Myelogenous Leukemia K562 Cell Line
155. The Mechanism Of MiR-409-3p On Suppressing Invasion And Metastases Of Gastric Cancer And The Role Of MiR-202 In Chemotherapy Sensitivity To CML
156. Serious Thrombocytopenia After Imatinib Treatment For CML-CP:A Case Report And Literature Review
157. Clinical Research Of Children With Chronic Myelogenous Leukemia Treated With Targeted Therapy
158. The Amplification Effect Of Microvesicles Produced By CML Cells On Myeloid-derived Suppressor Cells
159. Design, Synthesis And Evaluation Of Small Molecmle Drugs Against Chronic Myelogenous Leukemia
160. Study On Apoptosis Of Leukemia Cells Induced By Lycorine And The Caspase Pathway
  <<First  <Prev  Next>  Last>>  Jump to